NDRA ENDRA Life Sciences Inc.

-

ENDRA Life Sciences Beat Consensus Estimates

Friday, August 14, 2026 · 12:00 AM ET

ENDRA Life Sciences (NDRA) reported a loss of $0.63 per share on revenue of $0.00 million for the second quarter ended June 2026. The consensus estimate was a loss of $0.84 per share on revenue of $0.20 million. The company beat consensus estimates by 25.00%.

ENDRA Life Sciences Inc. is a developer of enhanced ultrasound technologies. ENDRA Life Sciences Inc. is based in Ann Arbor, United States.

Earnings Whisper Grade
Power Rating
Reported Earnings
($0.63)
Earnings Whisper®
Consensus Estimate
($0.84)
Earnings Surprise
Earnings Growth63.2 %
Reported Revenue
Revenue Estimate
$0.20M
Revenue Surprise
Revenue Growth